References
- Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000;355:949–55.
- Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Head and neck cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2011;9:596–650.
- Endo S, Suzuki S, Tsuji K, Nomura Y, Noguchi Y, Kida A, Concurrent chemoradiotherapy for advanced hypopharyngeal cancer. Nippon Jibiinkoka Gakkai Kaiho (Tokyo) 2005;108:980–5.
- Fukushima H, Kawabata K, Mitani H, Yoshimoto S, Yonekawa H, Beppu T, Surgery-based treatment of hypopharyngeal cancer. Jpn J Head Neck Cancer 2008;34:9–13.
- Taguchi T, Tsukuda M, Mikami Y, Matsuda H, Horiuchi C, Satake K, Concurrent chemoradiotherapy for patients with squamous cell carcinoma of the hypopharynx. Jpn J Head Neck Cancer 2007;33:309–13.
- Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma – treatment results in 138 consecutively admitted patients. Acta Otolaryngol 2000;39:529–36.
- Tombolini V, Santarelli M, Raffetto N, Donato V, Valeriani M, Ferretti A, Radiotherapy in the treatment of stage III-IV hypopharyngeal carcinoma. Anticancer Res 2004;24:349–54.
- Godballe C, Jørgensen K, Hansen O, Bastholt L. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. Laryngoscope 2002;112:834–8.
- Adelstein DJ, Levertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;88:876–83.
- Kubota A, Furukawa M, Hanamura H, Yamashita K, Sugiyama M. Concurrent chemoradiotherapy for squamous cell carcinoma of the hypopharynx. Jpn J Head Neck Cancer 2005;31:541–7.
- Tokumaru Y, Fujii M. Chemoradiotherapy for hypopharyngeal cancer. Stomato-Pharyngology 2012;25:41–6.
- Furusaka T, Asakawa T, Tanaka A, Matsuda H, Ikeda M. Efficacy of multi-drug superselective intra-arterial chemotherapy (docetaxel, cisplatin and 5-fluorouracil) using the Seldinger technique for tongue cancer. Acta Otolaryngol 2012;132:1108–14.
- Pignon JP, Syz N, Posner M, Olivares R, Le Lann L, Yver A, Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck. Anticancer Drugs 2004;15:331–40.
- Vermorken BJ, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695–704.
- Beauvillain C, Mahé M, Bourdin S, Peuvrel P, Bergerot P, Rivière A, Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope 1997;107:648–53.
- Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996;88:890–9.
- Furusaka T, Matsuda A, Tanaka A, Matsuda H, Ikeda M. Superselective intra-arterial chemotherapy for laryngeal preservation in carcinoma of the anterior oropharyngeal wall. Acta Otolaryngol 2012; [Epub ahead of print].
- Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364–71.
- Rasch CRN, Haupmann M, Schomagel J, Wijers O, Buter J, Gregor T, Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 2010;116:2159–65.